56
- Societies
- SOHC
- Categories
- Joint Session
Presidential Symposium
-
,
Boston 1-2
Presentation of the five SOHC Abstract Award Winners. Further details can be found under the following link: SOHC Awards 2025
-
Enhancing hemostasis in Glanzmann thrombasthenia via protein S inhibition
- Presentation time:
- 10 min
-
Feasibility of ctDNA and PET guided therapy in untreated DLBCL. preliminary results of the SAKK 38/19 phase II trial
- Presentation time:
- 10 min
-
Loss of SHP2 reduces JAK2V617F hematopoietic stem cell clone size and corrects MPN phenotype in preclinical models and patient cells
- Presentation time:
- 10 min
Speaker: Arunasalam* (Inselspital)
-
Single-dose carboplatin and involved-node radiotherapy for seminoma stage IIA/B: long-term follow-up from the international multicenter phase II trial SAKK 01/10
- Presentation time:
- 10 min
-
Young Survivors Registry – Prospective and Longitudinal Assessment of Health in Survivors of Childhood and Adolescent Cancer
- Presentation time:
- 10 min
Speaker: Otth (Ostschweizer Kinderspital)